Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Liver Disease: later-stage trial registry
4 of 6 indexed Chronic Liver Disease trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Chronic Liver Disease: 6 US clinical trials tracked, 4 recruiting.
Chronic Liver Disease is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Meridian Bioscience, running 1 of these trials.
Enrollment posture brief
Registry condition chronic-liver-disease
OPEN 4 | RECR 67% | LATE 2 | EARLY 0 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)
Chronic Liver Disease lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Liver Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Liver Disease is recruiting above its size-band peers.
4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Chronic Liver Disease research.
Meridian Bioscience accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Chronic Liver Disease enrolment sits around 400 participants.
Median target enrolment is 400 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.
-
Chronic Liver Disease splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Measuring Patient Reported Needs in Outpatient Liver Disease Management
Indiana University
NCT07191886
Endoscopic Ultrasound Shear Wave Elastography Study
Olympus Corporation of the Americas
NCT06592820
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Mercy Medical Center
NCT04588077
Copper Supplementation in Cirrhosis
University of Washington
NCT07471542
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
VA Connecticut Healthcare System
NCT01644656
BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis
Meridian Bioscience
NCT00736840
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Liver Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Liver Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Liver Disease page
6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Chronic Liver Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Meridian Bioscience sponsors the most Chronic Liver Disease trials on record, review their full trial history before evaluating a specific study. See Meridian Bioscience's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Liver Disease condition card totals 6 registered trials; most-linked intervention c13 methacetin solution with breath analyzer; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.